“A reduction in a jury award for a drug that caused cancer from $134 million to $58 million would not normally be cause to rejoice. But it has not been a normal year for hormone maker Wyeth. The Madison, N.J. based drug company faces 5,300 Prempro and Premarin related law suits in addition to the one it just lost–but with damages reduced–in Reno, NV brought by three women with breast cancer. Wyeth had asked Washoe District Judge Robert Perry for a mistrial. Selling a product that’s proven to cause cancer isn’t easy for Wyeth. In January, it announced it was selling the one million square-foot Rouses Point, N.Y plant where it made its horse-urine derived drugs and employed 900 and cutting a full ten percent of its work force.” (02/27/08)